NeuroScience Symposium 2023: Neurovascular Biology & Disorders, 2023_10_20

Friday, October 20, 2023, 7:00 AM - 5:00 PM CST, Samis Educational Center, Rainbolt Auditorium, Oklahoma City, OK

Target Audience: Physician, Advanced Practice Registered Nurse (APRN), Certified Registered Nurse Anesthetist (CRNA), Clinical Nurse Specialist (CNS), Fellow, Licensed Practical Nurse (LPN), Medical Student, Nurse, Nurse Practitioner (NP), Registered Nurse (RN), and Resident.

Specialties: Neurosurgery, Neurology, Neuroscience, Cardiovascular Diseases, Critical Care Medicine, Emergency Medicine, Family Medicine, General Medicine, Internal Medicine, Medical Education, and Research.

Symposium Description: Meeting theme for 2023: Vascular Neurobiology from Fundamentals to the Clinic: The symposium aims to highlight neuroscience on the greater OUHSC campus. The symposium lays the groundwork for cross-departmental collaboration between the neuroscience, neurosurgery, and other research programs across OUHSC including OMRF. The theme of this symposium will focus on topics in neuroscience each of which bridge basic, clinical, and translational components of neuroscience and neurosurgery. We will focus on recent advances in our understanding of the neuroscience and the diseases that impact the brain vasculature. The symposium will provide opportunities for neuroscience PhD students, residents and other trainees to display their exceptional work and interact with a broader medical and scientific community. We believe these interactions will spur new publications and grant applications as well as help us provide a means of displaying the amazing work already occurring on campus. The symposia will be geared to both neuroscientists as well as clinicians, highlighting both basic science concepts unique to the central nervous system as well as discussing the tremendous advances being made in this domain. The symposium will bring together the many talents from within and outside our medical campus and fosters enthusiasm for and advancement of neuroscience at OU. The theme of this symposium focuses on the integral role of clinical and basic neuroscience investigation and education on our medical research campus. We are excited by the growth of Neuroscience at OUHSC and OMRF. We seek to build upon the success of our inaugural Symposium in 2021 and growing enthusiasm for Neuroscience campus-wide. The 2023 Neuro-Symposium will be a joint collaborative effort between Neuroscience and Neurosurgery and the Center for Geroscience and Healthy Brain Aging (CfG) at OUHSC. There are many other stake-holders in neuroscience on campus, including Neuroscience, Neurosurgery, Pharmacy, Neurology, Psychiatry and neuroscience-related research at OMRF. The proposed meeting will bring together thought-leaders, and researchers at all levels from these individual programs on campus. It will also be an important forum for our students to present their work and interact with mentors and peers. We seek to establish the Neuroscience symposium as the campus-wide forum for neuroscience at the basic, translational, and clinical levels. Through this symposium, we will enhance the visibility of academic neuroscience on our campus and promote the exchange of ideas among students, researchers, and clinicians on campus to spur innovative new neuroscience research. We are building upon exceptional momentum from our first symposium event. An important new feature of the symposium will be time dedicated for the public to interact with and learn about the exceptional ongoing research and clinical discovery right here on campus. Our inaugural event featured two excellent, topically focused platform sessions dedicated to epilepsies and brain tumors, respectively, each of which span basic, clinical, and translational aspects of neuroscience and neurosurgery. Based on the success of that format, we will dedicate two platform sessions to vascular neurobiology spanning basic regulatory mechanisms to neurovascular dysfunction in disease, a topic of intense interest across the breadth of neuroscience. Each of these sessions will be capped by a keynote presentation from a leading expert in the fields, including one leader from outside of OUHSC and an OUHSC campus leader within neuroscience. In addition, a heavy focus will be on our students. We will have multiple sessions specifically dedicated to research performed by student, post-doctoral, and resident trainees in all areas of neuroscience. As detailed in this proposal, the Neuro-Symposium will provide an important vehicle to promote exchange of ideas, spur collaboration and innovation, and the development of Neuroscience research on campus. Establishment of a broad-based neuroscience research symposium is essential to growing neuroscience research as a center of excellence in Oklahoma. The 2022 symposium was attended by over 100 faculty, residents, and students from OUHSC, OMRF and the OU main campus. It had over 30 trainee research poster presentations originating from at least five different Ph.D. and resident training programs on campus were presented. This demonstrates the interest and need for a broad-based neuroscience symposium that embraces and co-ordinates with the various neuroscience-related departments, centers, and programs to grow the neurosciences here. A major goal of this symposium is to provide a yearly forum for graduate students, residents, and trainee investigators. The significance of this event will be important for their developing careers. At our inaugural symposia, we awarded 4 prizes for research. Students presented their posters to faculty and peers as well as through oral presentation. Further, they had the chance to sit at the dinner table with our keynote speakers, which included a R01-funded Department Chair and a Department Chair who also is editor-in-chief of a major journal. These experiences allow trainees the opportunity to practice scientific presentation, obtain feedback, and also make lasting connections with role models. Based upon direct feedback from our neuroscience students, we plan to further enhance the role of trainees in the next year’s symposium. We are committed to establishing the Neuro-Symposium as a vehicle for education, academic discourse, and to spur discovery and research collaboration at all levels on campus. Our long-term goal is to establish the Oklahoma Neuroscience Symposium as the central the hub for neuroscience research and education, by providing a platform for the exchange of ideas and to promote collaboration in the neurosciences at the basic, translational, and clinical levels across Oklahoma.

1. 1. Recognize and address microvascular cerebrovascular disorders that are overlooked as aging or silent issues. (K, C, P)
2. 2. Describe the severe neurological outcomes of microvascular cerebrovascular disorders.
3. 3. IDistinguish, manage and prevent potential irreversible health morbidities due to brain vasculature / microvascular cerebrovascular disorders.
4. 4. Identify and discuss the anatomy and physiological function brain vasculature plays in various neurological diseases. (K, C, P)
5. 5. Explain the complexity coupled with a lack of definitive guidelines in studying and manipulating brain vasculature (K, C, P).
6. 6. Determine the cutting-edge methods used to reduce cerebrovascular disease through brain vasculature (K, C, P).
7. 7. Illustrate the “best practices” in identifying and treating microvascular cerebrovascular disorders (K, C, P).
8. 8. Address the OUHSC multidisciplinary approach that includes non-academic individuals and groups to identify and treat the severe neurological outcomes of microvascular cerebrovascular disorders (K, C, P).
9. 9. Elaborate upon the diverse perspectives and research methodologies that enable researchers and practitioners to better tackle real-world patient care issues (K, C, P).
10. 10. Translate research results more efficiently into clinical and community care setting (C, P).

Registration Categories:
OUHSC and OU Health only (In-person only. Complimentary.)
Non-OUHSC and Non-OU Health (Virtual only. $50 registration fee.)

Upon registering, the registrants answer the following two questions:

Registration questions:

1. What is your profession (please identify)?
A. Physician and Fellow
B. Nurse
C. Other healthcare and research professional
D. Students: OUHSC (Allied Health, Dentistry, Graduate, Medicine, Nursing, Pharmacy, Public Health)
E. Students: Non-OUHSC (high school, undergraduate, graduate)
F. Other healthcare and research professionals

2. What credit do you qualify? 
A. AMA Category 1 credit
B. ANCC nursing hours/contact
C. Non-physician certificate of participation

Registration closes noon October 19, 2023.

Physician Continuing Education
ACCME/AMA PRA Accreditation Statement: The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education 
ANCC (American Nurses Credentialing Center) Accreditation Statement: OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

5.00 CNE contact hours will be awarded for meeting the following criteria: 90% attendance of conference, completion and submission of evaluation form.

This educational activity does not include any content that relates to the products and/or services of a commercial interest that would create a conflict of interest.

Mitigation Statement: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Nondiscrimination Statement: The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, housing, services in educational programs or activities, or health care services that the university operates or provides. Inquiries regarding non-discrimination policies may be directed to: Shaniqua Crawford, JD, Institutional Equity Officer and Title IX Coordinator, 405-325-3546, [email protected], or visit www.ou.edu/eoo.html. 

 Accommodations on the basis of disability are available by contacting Fauziyya Y. Muhammad, MD, PhD at (405) 271-8001, Extension 32281 or [email protected] as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

This activity received no commercial or in-kind support.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters identify all financial relationships with ineligible companies relating to the topics of this educational activity, and also disclose discussions of off-label or investigational drugs/devices and/or therapies during their presentation(s). 

AMA PRA Category 1 Credits™ (4.75 hours), ANCC Nursing Contact Hours (4.75 hours), Non-Physician Attendance (4.75 hours)

Mitigation of Relevant Financial Relationships

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Friday, October 20, 2023

Acknowledgement of Commercial and In-Kind Support: Commercial support is financial, or in-kind, contributions given by an ineligible company, which is used to pay all or part of the costs of a CME activity. An ineligible company is any company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

This activity received no commercial or in-kind support.